Cyclic vomiting syndrome versus inborn errors of metabolism: A review with clinical recommendations

Headache

Volumn 56, Issue 1, 2016, Pages 215-221

  Gelfand, Amy A ^a   Gallagher, Renata C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

abdominal migraine; cyclic vomiting syndrome; inborn error of metabolism; mitochondriopathy

Indexed keywords

CARNITINE; RIBOFLAVIN; UBIDECARENONE;

ACUTE INTERMITTENT PORPHYRIA; BLOOD ANALYSIS; CHILD; DISEASE ASSESSMENT; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; INBORN ERROR OF METABOLISM; MIGRAINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; UREA CYCLE DISORDER; URINALYSIS; VOMITING; GENETICS; LIPID METABOLISM, INBORN ERRORS; PATHOPHYSIOLOGY; PHENOTYPE;

HUMANS; LIPID METABOLISM, INBORN ERRORS; PHENOTYPE; VOMITING;

EID: 84956573446     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12749     Document Type: Review

References (48)

1. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33: 629-808.
2. Krams B, Echenne B, Leydet J, Rivier F, Roubertie A., Benign paroxysmal vertigo of childhood: Long-term outcome. Cephalalgia. 2011; 31: 439-443.
3. Batu ED, Anlar B, Topcu M, Turanli G, Aysun S., Vertigo in childhood: A retrospective series of 100 children. Eur J Paediatr Neurol. 2015; 19: 226-232.
4. Rosman NP, Douglass LM, Sharif UM, Paolini J., The neurology of benign paroxysmal torticollis of infancy: Report of 10 new cases and review of the literature. J Child Neurol. 2009; 24: 155-160.
5. Liao KY, Chang FY, Wu LT, Wu TC., Cyclic vomiting syndrome in Taiwanese children. J Formos Med Assoc. 2011; 110: 14-18.
6. Li BU, Murray RD, Heitlinger LA, Robbins JL, Hayes JR., Heterogeneity of diagnoses presenting as cyclic vomiting. Pediatrics. 1998; 102: 583-587.
7. Lee LY, Abbott L, Mahlangu B, Moodie SJ, Anderson S., The management of cyclic vomiting syndrome: A systematic review. Eur J Gastroenterol Hepatol. 2012; 24: 1001-1006.
8. Gee S., On fitful or recurrent vomiting. Saint Bartholomew's Hosp Rep. 1882; 18: 1-6.
9. Abu-Arafeh I, Russell G., Prevalence and clinical features of abdominal migraine compared with those of migraine headache. Arch Dis Child. 1995; 72: 413-417.
10. Paul Rosman N, Dutt M, Nguyen HT., A curable and probably often-overlooked cause of cyclic vomiting syndrome. Semin Pediatr Neurol. 2014; 21: 60-65.
11. Covanis A., Panayiotopoulos syndrome: A benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006; 118: e1237-1243.
12. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH., Cannabinoid hyperemesis: A case series of 98 patients. Mayo Clin Proc. 2012; 87: 114-119.
13. Rinaldo P., Mitochondrial fatty acid oxidation disorders and cyclic vomiting syndrome. Dig Dis Sci. 1999; 44: 97S-102S.
14. Kolker S, Cazorla AG, Valayannopoulos V, et al., The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: The initial presentation. J Inherit Metab Dis. 2015; 38: 1041-1057.
15. Fleisher DR, Matar M., The cyclic vomiting syndrome: A report of 71 cases and literature review. J Pediatr Gastroenterol Nutr. 1993; 17: 361-369.
16. Salpietro CD, Briuglia S, Merlino MV, Di Bella C, Rigoli L., A mitochondrial DNA mutation (A3243G mtDNA) in a family with cyclic vomiting. Eur J Pediatr. 2003; 162: 727-728.
17. El-Hattab AW, Adesina AM, Jones J, Scaglia F., MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015; 116: 4-12.
18. Zaki EA, Freilinger T, Klopstock T, et al., Two common mitochondrial DNA polymorphisms are highly associated with migraine headache and cyclic vomiting syndrome. Cephalalgia. 2009; 29: 719-728.
19. Boles RG, Zaki EA, Lavenbarg T, et al., Are pediatric and adult-onset cyclic vomiting syndrome (CVS) biologically different conditions? Relationship of adult-onset CVS with the migraine and pediatric CVS-associated common mtDNA polymorphisms 16519T and 3010A. Neurogastroenterol Motil. 2009; 21: e936-e972.
20. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB., Migraine prevalence by age and sex in the United States: A life-span study. Cephalalgia. 2010; 30: 1065-1072.
21. Moses J, Keilman A, Worley S, Radhakrishnan K, Rothner AD, Parikh S., Approach to the diagnosis and treatment of cyclic vomiting syndrome: A large single-center experience with 106 patients. Pediatr Neurol. 2014; 50: 569-573.
22. Venkatesan T, Zaki EA, Kumar N, et al., Quantitative pedigree analysis and mitochondrial DNA sequence variants in adults with cyclic vomiting syndrome. BMC Gastroenterol. 2014; 14: 181.
23. Fitzgerald M, Crushell E, Hickey C., Cyclic vomiting syndrome masking a fatal metabolic disease. Eur J Pediatr. 2013; 172: 707-710.
24. Olsen RK, Olpin SE, Andresen BS, et al., ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain. 2007; 130: 2045-2054.
25. Gardeitchik T, Humphrey M, Nation J, Boneh A., Early clinical manifestations and eating patterns in patients with urea cycle disorders. J Pediatr. 2012; 161: 328-332.
26. Rinaldo P, Matern D, Bennett MJ., Fatty acid oxidation disorders. Annu Rev Physiol. 2002; 64: 477-502.
27. Summar ML, Barr F, Dawling S, et al., Unmasked adult-onset urea cycle disorders in the critical care setting. Crit Care Clin. 2005; 21: S1-S8.
28. Patel KP, O'Brien TW, Subramony SH, Shuster J, Stacpoole PW., The spectrum of pyruvate dehydrogenase complex deficiency: Clinical, biochemical and genetic features in 371 patients. Mol Gen Metabol. 2012; 106: 385-394.
29. Ventura P, Cappellini MD, Biolcati G, Guida CC, Rocchi E, Gruppo Italiano P., A challenging diagnosis for potential fatal diseases: Recommendations for diagnosing acute porphyrias. Eur J Intern Med. 2014; 25: 497-505.
30. Abu-Salameh I, Plakht Y, Ifergane G., Migraine exacerbation during Ramadan fasting. J Headache Pain. 2010; 11: 513-517.
31. Drescher MJ, Alpert EA, Zalut T, Torgovicky R, Wimpfheimer Z., Prophylactic etoricoxib is effective in preventing Yom Kippur headache: A placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. Headache. 2010; 50: 1328-1334.
32. Drescher MJ, Wimpfheimer Z, Abu Khalef S, Gammaitoni A, Shehadeh N, Torgovicky R., Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: A placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. Headache. 2012; 52: 573-581.
33. Matarese CA, Mack KJ., Management considerations in the treatment of migraine in adolescents. Adolesc Health Med Ther. 2010; 1: 21-30.
34. Schoenen J, Jacquy J, Lenaerts M., Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurolory. 1998; 50: 466-470.
35. Hershey AD, Powers SW, Vockell AL, et al., Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine. Headache. 2007; 47: 73-80.
36. Rozen TD, Oshinsky ML, Gebeline CA, et al., Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia. 2002; 22: 137-141.
37. Sandor PS, Di Clemente L, Coppola G, et al., Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial. Neurology. 2005; 64: 713-715.
38. Slater SK, Nelson TD, Kabbouche MA, et al., A randomized, double-blinded, placebo-controlled, crossover, add-on study of coenzyme Q10 in the prevention of pediatric and adolescent migraine. Cephalalgia. 2011; 31: 897-905.
39. Di Lorenzo C, Pierelli F, Coppola G, et al., Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009; 72: 1588-1594.
40. Cornelius N, Byron C, Hargreaves I, et al., Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple acyl-CoA dehydrogenation deficiency. Hum Mol Gen. 2013; 22: 3819-3827.
41. Colombo B, Saraceno L, Comi G., Riboflavin and migraine: The bridge over troubled mitochondria. Neurol Sci. 2014; 35 (Suppl. 1): 141-144.
42. Zempleni J, Galloway JR, McCormick DB., Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nut. 1996; 63: 54-66.
43. O'Brien HL, Hershey AD., Vitamins and paediatric migraine: Riboflavin as a preventative medication. Cephalalgia. 2010; 30: 1417-1418.
44. McLoughlin LM, Trimble ER, Jackson P, Chong SK., L-carnitine in cyclical vomiting syndrome. Arch Dis Child. 2004; 89: 1180.
45. Van Calcar SC, Harding CO, Wolff JA., L-carnitine administration reduces number of episodes in cyclic vomiting syndrome. Clin Pediatr. 2002; 41: 171-174.
46. Boles RG., High degree of efficacy in the treatment of cyclic vomiting syndrome with combined co-enzyme Q10, L-carnitine and amitriptyline, a case series. BMC Neurol. 2011; 11: 102.
47. Li BU, Lefevre F, Chelimsky GG, et al., North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2008; 47: 379-393.
48. Cristofori F, Thapar N, Saliakellis E, et al., Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014; 40: 309-317.